Buchumschlag

Exosome‐Based Detection of Helicobacter pylori Infection and Clarithromycin Resistance in Children

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Minghui Song, Jingqing Zeng, Zhanyong Yao, Chundi Xu, Yiqiu Huang, Yuan Xiao, Yi Yu, Jia Li, Xu Xu, Chenchen Shi, Qiuchen Wu, Yonglin Tao, Xing Tang, Gloria Ge, Shenshen Gao, Zhaohui Deng, Xinqiong Wang
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2026
Schlagworte:	Helicobacter
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Helicobacter pylori Infection in Children: To Eradicate or Not to Eradicate?
von: Marco Manfredi, et al.
Veröffentlicht: (2024)

Droplet Digital PCR ‐Based Detection of Clarithromycin Resistance on Rapid Urease Test Samples Predicts Helicobacter pylori Eradication Success: A New Zealand Cohort Study
von: Stephen James Inns, et al.
Veröffentlicht: (2025)

Changes of Helicobacter pylori Infection Status and Risk of Precancerous Lesions: A Prospective Cohort Study in Chinese Population
von: Xufei Xing, et al.
Veröffentlicht: (2026)

Artificial Intelligence‐Generated Patient Education Materials for Helicobacter pylori Infection: A Comparative Analysis
von: Shuyan Zeng, et al.
Veröffentlicht: (2024)

Innate Immunity in Helicobacter pylori Infection and Gastric Oncogenesis
von: Yuheng Zhang, et al.
Veröffentlicht: (2025)

Host Genetic Variants Associated With Helicobacter pylori Infection: A Meta‐Analysis Combined With Functional Annotation
von: Wen‐Jing Zhao, et al.
Veröffentlicht: (2025)

Tracking the Helicobacter pylori Epidemic in Adults and Children in China
von: Zixing Wang, et al.
Veröffentlicht: (2024)

Clarifying varied Helicobacter pylori eradication therapies: A comprehensive review
von: Xiaoqi Wu, et al.
Veröffentlicht: (2024)

Assessing Accuracy of ChatGPT on Addressing Helicobacter pylori Infection‐Related Questions: A National Survey and Comparative Study
von: Yi Hu, et al.
Veröffentlicht: (2024)

Factors Associated With Decision to Treat or Not to Treat Helicobacter pylori Infection in Children: Data From the EuroPedHp Registry
von: Thu Giang Le Thi, et al.
Veröffentlicht: (2024)

Correlation of FUT3 and FUT6 Gene Polymorphisms With Helicobacter pylori Infection
von: Shihang Zhou, et al.
Veröffentlicht: (2024)

Lipidome Characterization Reveals Alterations of Fatty Acid Metabolism in Helicobacter pylori Infection
von: Hyder Alikhan, et al.
Veröffentlicht: (2025)

Antimicrobial Resistance of Helicobacter pylori Isolated From Latin American Children and Adolescents (2008–2023): A Systematic Review
von: Camila Cabrera, et al.
Veröffentlicht: (2024)

Interpretation the Results of Eradicating Helicobacter pylori Infection Causing Colorectal Cancer Could Be Cautious
von: Lo‐Yip Yu, et al.
Veröffentlicht: (2025)

Incorporating Helicobacter pylori Infection: A Novel Model for Predicting Advanced Colorectal Neoplasia
von: Xujin Chen, et al.
Veröffentlicht: (2026)

First Report of National Consensus Guidelines for the Diagnosis and Treatment of Helicobacter pylori Infection in Iran
von: Aryan Salahi‐Niri, et al.
Veröffentlicht: (2026)

Correction to Antimicrobial Resistance of Helicobacter pylori Isolated From Latin American Children and Adolescents (2008–2023): A Systematic Review
Veröffentlicht: (2024)

Helicobacter pylori infection and inflammasomes
von: Huiling Zheng, et al.
Veröffentlicht: (2024)

Elucidating the Pathogenic Role of Helicobacter pylori Infection in Hematologic Disorders: Mechanistic Insights and Future Perspectives
von: Kimia Fathalizade, et al.
Veröffentlicht: (2026)

A Bidirectional Association Between Helicobacter pylori Infection and Hyperlipidemia: Clinical Evidence and Mechanistic Insights
von: Yan'an Zhou, et al.
Veröffentlicht: (2026)

Proteomic Profiling of Extracellular Vesicles Reveals Potential Biomarkers for Helicobacter pylori Infection and Gastric Cancer
von: Phawinee Subsomwong, et al.
Veröffentlicht: (2025)

Artificial Intelligence in Endoscopy for Predicting Helicobacter pylori Infection: A Systematic Review and Meta‐Analysis
von: Yiwen Jiang, et al.
Veröffentlicht: (2025)

Reply: Is Tailored Bismuth Quadruple Therapy (With Clarithromycin or Furazolidone) Based on Fecal Molecular Susceptibility Testing in First‐Line Helicobacter pylori Eradication Treatment More Effective? A Three‐Arm, Multicenter Randomized Clinical Trial
von: Xinlu Ren, et al.
Veröffentlicht: (2025)

Efficacy of Bismuth Therapy in Eradicating Helicobacter pylori in Children—Data From the RENIHp Registry
von: Gonzalo Botija, et al.
Veröffentlicht: (2024)

Global Prevalence of Helicobacter pylori Infection‐Associated Gastric Preneoplastic Lesions in Pediatric Patients: A Systematic Review and Meta‐Analysis
von: Mohammed Awadh Abdun, et al.
Veröffentlicht: (2025)

Expansion of cagA Copy Number in Helicobacter pylori During Co‐Infection in a Mouse Model
von: Kavinda Tissera, et al.
Veröffentlicht: (2025)

Characterization of Fecal Microbial Communities in Patients With Type 2 Diabetes Mellitus Combined With Helicobacter pylori Infection
von: Xiaoyan He, et al.
Veröffentlicht: (2025)

Correction to “Letter to the Editor: ‘Parietal Cell Antibody Levels Among Chronic Gastritis Patients in a Country With Low Helicobacter pylori Infection: Epidemiology, Histopathological Features, and H. pylori Infection’”
Veröffentlicht: (2025)

Authors' Reply to the Letter on “Is Tailored Bismuth Quadruple Therapy (With Clarithromycin or Furazolidone) Based on Fecal Molecular Susceptibility Testing in First‐Line Helicobacter pylori Eradication Treatment More Effective? A Three‐Arm, Multicenter Randomized Clinical Trial”
von: Zhengchen Yu, et al.
Veröffentlicht: (2025)

Efficacy of Bismuth Quadruple Therapy in the Treatment of Helicobacter pylori‐Infected Peptic Ulcer Children in Vietnam
von: Thi Minh Phuong Do, et al.
Veröffentlicht: (2024)

Efficacy and Safety of Vonoprazan‐Based Dual, Triple, and Quadruple Therapies for Helicobacter pylori Eradication: A Randomized Controlled Trial
von: Jin‐Yan Zhang, et al.
Veröffentlicht: (2026)

Fourteen‐Day Tegoprazan–Amoxicillin Dual Therapy as the First‐Line Treatment of Helicobacter pylori Infection (SHARE2301): A Multicenter, Noninferiority, Randomized Clinical Trial
von: Qingzhou Kong, et al.
Veröffentlicht: (2024)

Treatment failure is a key factor in the development of Helicobacter pylori resistance
von: Jinliang Xie, et al.
Veröffentlicht: (2024)

Candidate Antigens and the Development of Helicobacter pylori Vaccines
von: Zhanhua Zhang, et al.
Veröffentlicht: (2024)

Combatting Helicobacter pylori: A Focus on Nanomaterials
von: Xuanping Wang, et al.
Veröffentlicht: (2024)

Assessing the Capabilities of Novel Open‐Source Artificial Intelligence—DeepSeek in Helicobacter pylori‐Related Queries
von: Ren‐Chun Du, et al.
Veröffentlicht: (2025)

Management of Helicobacter pylori Infection in Spain Beyond the Data Collected in the European Registry on H. pylori Management (Hp‐EuReg): Results of a Nationwide Survey
von: Javier Tejedor‐Tejada, et al.
Veröffentlicht: (2025)

Vonoprazan–Amoxicillin Dual Therapy With Different Amoxicillin Administration Regimens for Helicobacter pylori Treatment: A Randomized Controlled Trial
von: Shuhan Qiu, et al.
Veröffentlicht: (2024)

Efficacy of Three Amoxicillin Doses in Vonoprazan Dual Therapy for Helicobacter pylori Eradication: A Randomized Noninferiority Trial
von: Ruolin Peng, et al.
Veröffentlicht: (2025)

Effect of Lactobacillus gasseri BIO 6369 and Lacticaseibacillus rhamnosus BIO 5326 on Gastric Carcinogenesis Induced by Helicobacter pylori Infection
von: Marine Jauvain, et al.
Veröffentlicht: (2024)